Concepedia

Eli Ipp

EI

Statistics

Publications

83

Citations

5.6K

H-Index

39

Active since

1969

Affiliations

UCLA Medical Center(Current)

Harbor–UCLA Medical Center

The Lundquist Institute

University of California, Los Angeles

The University of Texas Southwestern Medical Center

Eli Ipp is an author at UCLA Medical Center specializing in diabetes mellitus, medicine, and endocrinology.

Publications per year

1969–2024

83

Publications

83

Genetic drivers of heterogeneity in type 2 diabetes pathophysiology

Ken Suzuki, Konstantinos Hatzikotoulas, Lorraine Southam et al. · Nature · 2024 · 513 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · The Lancet Diabetes & Endocrinology · 2017 · 292 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

Paresh Dandona, Pieter Gillard, Peter Senior et al. · Diabetes Care · 2018 · 252 citations

Medicine, Pharmacology, Pharmacotherapy +15

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · Diabetes Care · 2018 · 238 citations

Medicine, Pharmacology, Pharmacotherapy +17

Morphine and β-endorphin influence the secretion of the endocrine pancreas

Eli Ipp, Richard Dobbs, Roger H. Unger · Nature · 1978 · 235 citations

Life Sciences, Pharmacology, Physiology +14

1–5 of 83